EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders

Xiaorui Xiong iD, Stephen Braun iD, Maxine Stitzer, Hilary Luderer iD, Gigi Shafai, Brendan Hare iD, Michael Stevenson, Yuri Maricich iD

The American Journal on Addictions · 2023-01 · 32 (1) · 24-31

DOI: 10.1111/ajad.13346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal on Addictions, online erschienen am 20.10.2022. Verfasst von Xiaorui Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Pear Therapeutics (US), Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Substance-Related Disorders. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Digital therapeutics can expand the reach and fidelity of behavioral treatment for substance use disorders (SUDs). This analysis evaluated real‐world engagement and clinical outcomes in patients diagnosed with SUD who were prescribed reSET®, an FDA‐authorized prescription digital therapeutic (PDT).

Methods

Patients were prescribed a 12‐week PDT comprising 61 therapy lessons (31 “core” and 30 “keep learning” lessons) and contingency management rewards (positive reinforcement message or monetary gift cards) based on lesson completion and negative urine drug screens. Engagement (defined as any activity in the PDT), retention (any activity in Weeks 9–12), and substance use data were collected automatically by the PDT and analyzed descriptively. Associations between early lesson completion and end‐of‐treatment outcomes were assessed.

Results

Six hundred and fifty‐eight patients filled their prescription. Evaluated were 602 patients who were exposed to therapeutic content by completing at least one lesson (median age 37 years, 33% female, 41% male, 26% unreported sex). Median lessons completed was 33 (out of 61 possible), and 52% of patients completed all core modules. Retention in treatment during the last 4 weeks of treatment was 74%, and 62% were abstinent (missing data considered positive). [Correction added on 13 December 2022, after first online publication: In the preceding sentence, the treatment percentage values were revised from 74.6% to 74%.] Discussion and Conclusions Patients with SUD exhibited robust engagement with a PDT, high rates of retention through 12 weeks, and substantial rates of abstinence at end of treatment when the therapeutic was used in a real‐world setting. PDT's hold promise as a new way to access effective SUD treatment. Scientific Significance This study is the first to report real‐world PDT engagement and clinical outcomes data from a large, geographically diverse population of patients with SUDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersHumansMaleFemaleAdultBehavior TherapyTreatment OutcomePrescriptions

Autor:innen und Institutionen

  • Medical Affairs, Pear Therapeutics (US), Boston, Massachusetts, USA.
  • Behavioral Pharmacology Research Unit, Friends Research Institute, Baltimore, Maryland, USA.

ORCID-Profile: Xiaorui Xiong, Stephen Braun, Hilary Luderer, Brendan Hare, Yuri Maricich

Zitieren

APA

Xiong, X., Braun, S., Stitzer, M., Luderer, H., Shafai, G., Hare, B., Stevenson, M., & Maricich, Y. (2023). Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. The American Journal on Addictions, 32(1), 24-31. https://doi.org/10.1111/ajad.13346

Vancouver

Xiong X, Braun S, Stitzer M, Luderer H, Shafai G, Hare B, et al. Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. The American Journal on Addictions. 2023;32(1):24-31. doi:10.1111/ajad.13346

BibTeX
@article{Xiong2023,
  author = {Xiong, Xiaorui and Braun, Stephen and Stitzer, Maxine and Luderer, Hilary and Shafai, Gigi and Hare, Brendan and Stevenson, Michael and Maricich, Yuri},
  title = {Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders},
  journal = {The American Journal on Addictions},
  year = {2023},
  volume = {32},
  number = {1},
  pages = {24--31},
  doi = {10.1111/ajad.13346}
}
Kostenlos starten →